Breast cancer (BC) is classified into four categories based on the expression of hormone receptors (HRs): estrogen receptor positive (ER+), progesterone receptor positive (PR+), and human epidermal growth factor receptor positive (HER2+). This evidence concerns the gene ERBB2 and breast cancer.